Overview
GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Eligibility
Inclusion Criteria:
- refer to the GZPL master protocol for screening eligibility.
Exclusion Criteria:
- refer to the GZPL master protocol for screening eligibility.